Literature DB >> 11147825

Mouse lacking NAD+-linked glycerol phosphate dehydrogenase has normal pancreatic beta cell function but abnormal metabolite pattern in skeletal muscle.

M J MacDonald1, L K Marshall.   

Abstract

We surveyed the BALB/cHeA mouse, which lacks cytosolic glycerol phosphate dehydrogenase an enzyme that catalyzes a reaction in the glycerol phosphate shuttle. The other enzyme of this shuttle, mitochondrial glycerol phosphate dehydrogenase, is abundant in skeletal muscle and pancreatic islets suggesting that the shuttle's activity is high in these tissues. Levels of glycerol phosphate (low) and dihydroxyacetone phosphate (high) were very abnormal in nonislet tissue, especially in skeletal muscle. Intermediates situated before the triose phosphates in the glycolysis pathway were increased and those after the triose phosphates were generally low, depending on the tissue. The lactate/pyruvate ratio in muscle was low signifying a low cytosolic NAD/NADH ratio. This suggests that a nonfunctional glycerol phosphate shuttle caused a block in glycolysis at the step catalyzed by glyceraldehyde phosphate dehydrogenase. When exercised, mice were unable to maintain normal ATP levels in skeletal muscle. Blood glucose, serum insulin levels, and pancreatic islet mass were normal. In isolated pancreatic islets insulin release, glucose metabolism and ATP levels were normal, but lactate levels and lactate/pyruvate ratios with a glucose load were slightly abnormal. The BALB/cHeA mouse can maintain NAD/ NADH ratios sufficient to function normally under most conditions, but the redox state is not normal. Glycerol phosphate is apparently formed at a slow rate. Skeletal muscle is severely affected probably because it is dependent on the glycerol phosphate shuttle more than other tissues. It most likely utilizes glycerol phosphate rapidly and, due to the absence of glycerol kinase in muscle, is unable to rapidly form glycerol phosphate from glycerol. Glycerol kinase is also absent in the pancreatic insulin cell, but this cell's function is essentially normal probably because of redundancy of NAD(H) shuttles.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11147825     DOI: 10.1006/abbi.2000.2107

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  25 in total

1.  GATA-binding protein 4 (GATA-4) and T-cell acute leukemia 1 (TAL1) regulate myogenic differentiation and erythropoietin response via cross-talk with Sirtuin1 (Sirt1).

Authors:  Li Wang; Yi Jia; Heather Rogers; Yun-Ping Wu; Suming Huang; Constance Tom Noguchi
Journal:  J Biol Chem       Date:  2012-07-07       Impact factor: 5.157

2.  Potent humanin analog increases glucose-stimulated insulin secretion through enhanced metabolism in the β cell.

Authors:  Regina Kuliawat; Laura Klein; Zhenwei Gong; Marianna Nicoletta-Gentile; Anjana Nemkal; Lingguang Cui; Claire Bastie; Kai Su; Derek Huffman; Manju Surana; Nir Barzilai; Norman Fleischer; Radhika Muzumdar
Journal:  FASEB J       Date:  2013-08-30       Impact factor: 5.191

Review 3.  The Response to Stimulation in Neurons and Astrocytes.

Authors:  Inés Juaristi; Laura Contreras; Paloma González-Sánchez; Irene Pérez-Liébana; Luis González-Moreno; Beatriz Pardo; Araceli Del Arco; Jorgina Satrústegui
Journal:  Neurochem Res       Date:  2019-04-23       Impact factor: 3.996

Review 4.  NAD+ metabolism and oxidative stress: the golden nucleotide on a crown of thorns.

Authors:  Hassina Massudi; Ross Grant; Gilles J Guillemin; Nady Braidy
Journal:  Redox Rep       Date:  2012       Impact factor: 4.412

Review 5.  The mitochondrial paradigm for cardiovascular disease susceptibility and cellular function: a complementary concept to Mendelian genetics.

Authors:  David M Krzywanski; Douglas R Moellering; Jessica L Fetterman; Kimberly J Dunham-Snary; Melissa J Sammy; Scott W Ballinger
Journal:  Lab Invest       Date:  2011-06-06       Impact factor: 5.662

6.  A compound heterozygous mutation in GPD1 causes hepatomegaly, steatohepatitis, and hypertriglyceridemia.

Authors:  Mugdha Joshi; Jacqueline Eagan; Nirav K Desai; Stephanie A Newton; Meghan C Towne; Nicholas S Marinakis; Kristyn M Esteves; Sarah De Ferranti; Michael J Bennett; Adam McIntyre; Alan H Beggs; Gerard T Berry; Pankaj B Agrawal
Journal:  Eur J Hum Genet       Date:  2014-02-19       Impact factor: 4.246

7.  Single sample extraction protocol for the quantification of NAD and NADH redox states in Saccharomyces cerevisiae.

Authors:  Jennifer L Sporty; Md Mohiuddin Kabir; Kenneth W Turteltaub; Ted Ognibene; Su-Ju Lin; Graham Bench
Journal:  J Sep Sci       Date:  2008-10       Impact factor: 3.645

8.  Expanding the molecular diversity and phenotypic spectrum of glycerol 3-phosphate dehydrogenase 1 deficiency.

Authors:  Carlo Dionisi-Vici; Eyal Shteyer; Marcello Niceta; Cristiano Rizzo; Ben Pode-Shakked; Giovanni Chillemi; Alessandro Bruselles; Michela Semeraro; Ortal Barel; Eran Eyal; Nitzan Kol; Yael Haberman; Avishai Lahad; Francesca Diomedi-Camassei; Dina Marek-Yagel; Gideon Rechavi; Marco Tartaglia; Yair Anikster
Journal:  J Inherit Metab Dis       Date:  2016-07-01       Impact factor: 4.982

9.  Enzymes of glycerol and glyceraldehyde metabolism in mouse liver: effects of caloric restriction and age on activities.

Authors:  Kevork Hagopian; Jon J Ramsey; Richard Weindruch
Journal:  Biosci Rep       Date:  2008-04       Impact factor: 3.840

10.  Overexpression of the malate-aspartate NADH shuttle member Aralar1 in the clonal beta-cell line BRIN-BD11 enhances amino-acid-stimulated insulin secretion and cell metabolism.

Authors:  Katrin Bender; Pierre Maechler; Neville H McClenaghan; Peter R Flatt; Philip Newsholme
Journal:  Clin Sci (Lond)       Date:  2009-09-01       Impact factor: 6.124

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.